Work

Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies

Year: 2022

Type: editorial

Abstract: EDITORIAL article Front. Immunol., 06 September 2022Sec. Cancer Immunity and Immunotherapy Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1023967

Source: Frontiers in Immunology

DOI: 10.3389/fimmu.2022.1023967

Authors: Jianmei W. Leavenworth, Xindong Liu, Yunfeng Ma, Yibei Zhu, Chunjian Qi

Institutions: University of Alabama at Birmingham, UAB Medicine, O'Neal Comprehensive Cancer Center, Army Medical University, Southwest Hospital, Xi'an Jiaotong University, Soochow University, Changzhou No.2 People's Hospital, Nanjing Medical University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,950

Funder: National Institute of Allergy and Infectious Diseases

Award: G2859268975

OpenAlex ID: W4294740944

Cites: 10

Cited by: 2

Related to: 10